Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria

M K Rai1, S D Deshmukh, A P Ingle

  • 1Department of Biotechnology, Sant Gadge Baba Amravati University, Amravati, Maharashtra, India. mkrai123@rediffmail.com

Insights

Multidrug-resistant (MDR) microbes pose a significant threat, driving the need for new antimicrobials. Silver nanoparticles show promise as a potent weapon against these resistant bacteria, offering hope for effective treatment and prevention.

Area of Science:

  • Pharmaceutical science
  • Biomedical research
  • Nanotechnology

Background:

  • The rise of multidrug-resistant (MDR) pathogenic microbes presents a critical challenge to the pharmaceutical and biomedical sectors.
  • Antibiotic resistance in microbes is a survival mechanism that leads to increased mortality, morbidity, and treatment costs.
  • Traditional Ayurvedic medicine has utilized silver compounds for treating bacterial infections for centuries.

Purpose of the Study:

  • To review the bactericidal potential of silver nanoparticles (AgNPs) against multidrug-resistant (MDR) bacteria.
  • To explore AgNPs as a novel therapeutic strategy for combating drug-resistant microbial infections.

Main Methods:

  • Literature review focusing on studies investigating the efficacy of silver nanoparticles against MDR bacteria.
  • Analysis of the mechanisms of action of AgNPs in inhibiting or killing resistant microbial strains.

Main Results:

  • Silver nanoparticles exhibit significant bactericidal activity against a range of MDR pathogenic bacteria.
  • AgNPs offer a multi-actional approach, targeting bacteria through various mechanisms.

Conclusions:

  • Silver nanoparticles represent a promising therapeutic agent for the treatment and prevention of infections caused by multidrug-resistant bacteria.
  • The unique properties of AgNPs make them a valuable tool in the ongoing battle against antimicrobial resistance.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...